Dan Tehan slams the government's energy transition as solar farms face forced shutdowns amid grid bottleneck crisis
His comments come in the wake of alarming new forecasts from the Australian Energy Market Operator (AEMO), which reveal that nearly every major solar farm in Victoria and South Australia will be required to curtail at least one third of their output by 2027 due to grid congestion.
Some projects are expected to lose more than 65 per cent of their generation capacity.
In an interview with Sky News, Mr Tehan laid blame squarely on Energy Minister Chris Bowen, accusing him of ignoring the real-world cost of the transition and failing to deliver the infrastructure needed to support it.
"Well, the problem is that Chris Bowen's made a complete mess of our electricity transition,' he said.
"Everywhere you look, it's a mess. And the one thing that he doesn't want to answer is, what is the cost of this mess?
"We know that his plans don't take into consideration the cost of this rollout of new poles and wires. He won't put a figure on it. We now know that that's delayed.
"So, what does that mean when it comes to the grid's reliability going forward, and also what does it mean for consumers?"
With key projects like the $3.3 billion VNI West interconnector now facing multi-year delays, the energy grid is struggling to accommodate the surge in renewables production, leaving solar farms with no choice but to shut down during periods of peak generation.
Mr Tehan also took aim at the broader approach to renewables in Victoria, where much of the grid congestion is concentrated.
"It's because they've focused on this renewables only approach and they've completely demonised gas - they've completely demonised the idea that we should have gas peaking plants and now in Victoria, to try and overcome these delays, they're taking property rights away from farmers," he said.
AEMO has warned that unless key transmission lines are fast-tracked, large-scale solar farms will increasingly be forced offline, even as coal plants close and the grid becomes more dependent on renewable sources.
For Mr Tehan, the solution lies in abandoning the narrow focus on renewables and adopting a more balanced, technology-neutral strategy.
"If they had a technology-neutral approach we wouldn't be in the mess that we are in at the moment," the shadow energy minister said.
"Everyone says we need more gas into the systems and rather than running roughshod over communities when it comes to putting increased grid costs on everyone, look at simple things you can do right here and how to alleviate costs on power bills, but also making sure that you're going to have a much more stable system going forward."
The Coalition has long criticised Labor's handling of the energy transition, arguing that excluding technologies like gas from the long-term plan would put Australia's energy security at risk.
With energy prices continuing to rise and reliability coming under threat, Mr Tehan said Australians are being left to pick up the tab for policy failure.
"The message from these customers to Chris Bowen, who is sunning himself in the Pacific Island at the moment, is they want an apology because Chris Bowen promised these customers a $275 reduction in their power bills, and yet here he is when they get another increase saying, 'oh, we've got this under review'.
'Everywhere you look, it's just a mess."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Perth Now
26 minutes ago
- Perth Now
Labor vows to ‘fight' as Trump threatens pharma tariffs
Health Minister Mark Butler says the Albanese government will 'fight for the PBS'. Martin Ollman / NewsWire Health Minister Mark Butler says the Albanese government will 'fight for the PBS'. Martin Ollman / NewsWire Credit: News Corp Australia The Albanese government is vowing to 'fight for the PBS' as Donald Trump tries to strongarm drugmakers into moving production to the US. The Pharmaceutical Benefits Scheme (PBS) is a list of federally subsidised medicines and a prized Labor invention. Health Minister Mark Butler last month introduced legislation that, if passed, would cap PBS-listed medicines at $25 from January 1, 2026. Aside from subsidising medicines, the scheme also compels firms to negotiate prices with the federal government, which helps keep products affordable. Celebrated as a cornerstone of the healthcare system in Canberra, the scheme is denounced by pharmaceutical lobbyists in Washington, who claim Australia is 'freeloading on American innovation'. One group, Pharmaceutical Research and Manufacturers of America (PhRMA), has explicitly urged the Trump administration to 'leverage ongoing trade negotiations' to influence Australia's PBS policies. But Anthony Albanese, Mr Butler and other ministers have ruled out budging on the PBS. 'We'll fight for our PBS and fight for the jobs of Australian manufacturers here,' Mr Butler told the ABC on Friday, noting most production is in Melbourne. Pharmaceutical exports to the US totalled north of $2bn in 2024, making it the biggest foreign market for Australian producers. Exports are mostly blood products and vaccines but also include packaged medicines and miscellaneous medical items, such as bandages. Though, as Mr Butler noted, the US still exported more to Australia and did so without tariffs. 'We have zero tariffs on those imports that we take from America companies,' he said. 'We're making the case that should continue in reverse. 'We should be able to continue to export our terrific blood and plasma products and medicines to Americans without what might be a 250 per cent tariff.' Camera Icon Health Minister Mark Butler says the Albanese government will 'fight for the PBS'. Martin Ollman / NewsWire Credit: News Corp Australia For the moment, Mr Trump's concern with the sector appears to be largely driven by bringing down prices in the US rather than punishing allies for having cheaper medicines. Last week, he wrote to 17 major pharmaceutical companies demanding they lower their prices for American consumers to bring them in line with prices overseas. A Rand Corporation report found that Americans pay nearly four times more than Australians for medicines and about three times more than the average in other developed economies. The answer, according to Mr Trump, is making pharmaceuticals in the US. Mr Trump's 250 per cent tariff threat was a warning shot to firms, but one that, if realised, would hit producers Down Under hard.

News.com.au
an hour ago
- News.com.au
Labor vows to ‘fight' as Trump threatens pharma tariffs
The Albanese government is vowing to 'fight for the PBS' as Donald Trump tries to strongarm drugmakers into moving production to the US. The Pharmaceutical Benefits Scheme (PBS) is a list of federally subsidised medicines and a prized Labor invention. Health Minister Mark Butler last month introduced legislation that, if passed, would cap PBS-listed medicines at $25 from January 1, 2026. Aside from subsidising medicines, the scheme also compels firms to negotiate prices with the federal government, which helps keep products affordable. Celebrated as a cornerstone of the healthcare system in Canberra, the scheme is denounced by pharmaceutical lobbyists in Washington, who claim Australia is 'freeloading on American innovation'. One group, Pharmaceutical Research and Manufacturers of America (PhRMA), has explicitly urged the Trump administration to 'leverage ongoing trade negotiations' to influence Australia's PBS policies. But Anthony Albanese, Mr Butler and other ministers have ruled out budging on the PBS. 'We'll fight for our PBS and fight for the jobs of Australian manufacturers here,' Mr Butler told the ABC on Friday, noting most production is in Melbourne. Pharmaceutical exports to the US totalled north of $2bn in 2024, making it the biggest foreign market for Australian producers. Exports are mostly blood products and vaccines but also include packaged medicines and miscellaneous medical items, such as bandages. Though, as Mr Butler noted, the US still exported more to Australia and did so without tariffs. 'We have zero tariffs on those imports that we take from America companies,' he said. 'We're making the case that should continue in reverse. 'We should be able to continue to export our terrific blood and plasma products and medicines to Americans without what might be a 250 per cent tariff.' For the moment, Mr Trump's concern with the sector appears to be largely driven by bringing down prices in the US rather than punishing allies for having cheaper medicines. Last week, he wrote to 17 major pharmaceutical companies demanding they lower their prices for American consumers to bring them in line with prices overseas. A Rand Corporation report found that Americans pay nearly four times more than Australians for medicines and about three times more than the average in other developed economies. The answer, according to Mr Trump, is making pharmaceuticals in the US. Mr Trump's 250 per cent tariff threat was a warning shot to firms, but one that, if realised, would hit producers Down Under hard.

AU Financial Review
an hour ago
- AU Financial Review
Cash for access: The private meetings earning Labor millions
The Albanese government has moved to keep private the details of dozens of meetings attended by senior ministers with business executives and lobbyists, which were facilitated by Labor's fundraising program, in a move that transparency experts have roundly criticised. Prime Minister Anthony Albanese and his ministers attended a dinner on Thursday night in Sydney for members of the Federal Labor Business Forum, who pay up to $110,000 for privileged access. Tickets were on sale for $2500 per person or $18,000 a table for non-members.